Stockreport

Sorrento Therapeutics and Celularity Aim to Adapt Natural Killer Cell Therapy to Treat Coronavirus [The Motley Fool]

Sorrento Therapeutics, Inc.  (SRNE) 
Last sorrento therapeutics, inc. earnings: 8/9 04:49 pm Check Earnings Report
US:NASDAQ Investor Relations: sorrentotherapeutics.com/investors
PDF Sorrento Therapeutics and Celularity Aim to Adapt Natural Killer Cell Therapy to Treat Coronavirus [Read more]